SAM
RXDX
Sectoral Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-108,090
| Closed | -$11.6M | – | 132 |
|
|
2023
Q1 | $11.6M | Sell |
108,090
-4,120
| -4% | -$442K | 2.23% | 6 |
|
|
2022
Q4 | $12.3M | Buy |
112,210
+9,000
| +9% | +$990K | 2.39% | 6 |
|
|
2022
Q3 | $6.09M | Sell |
103,210
-69,295
| -40% | -$4.09M | 1.2% | 29 |
|
|
2022
Q2 | $4.87M | Buy |
+172,505
| New | +$4.87M | 0.98% | 43 |
|